Michael Metzger, President & CEO, Director at Tobira Therapeutics, holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA), holds 0.00 shares in CTI BioPharma (Ticker: CTIC), holds 17.66K shares in Syndax Pharmaceuticals (Ticker: SNDX). Most recently, Michael Metzger ― shares of Tobira Therapeutics on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Michael Metzger?
The percentage of profitable transactions made by Michael Metzger is ―.
What is the average return per transaction made by Michael Metzger?
The average return per transaction made by Michael Metzger is ―.
What stocks does Michael Metzger hold?
Michael Metzger holds: TBRA, CTIC, SNDX, RGDXQ stocks.
What was Michael Metzger’s latest transaction?
Michael Metzger latest transaction was an Uninformative Buy of ―.
What was Michael Metzger's most profitable transaction?
Michael Metzger’s most profitable transaction was an Informative Buy of RGDXQ stock on February 6, 2012. The return on the trade was -22.20%.
What is Michael Metzger's role in Tobira Therapeutics?
Michael Metzger's role in Tobira Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.